Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | CRHBP | P24387 | 1/20 | 0.41 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.41 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | P2RX7 | Q99572 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29569492 | 1.00 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2CYP1A2CYP2C19RAB9A | |
| SCHEMBL3121724 | 0.83 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2CYP1A2CYP2C19RAB9A | |
| SCHEMBL189219 | 0.82 | HTR2A (0.39) | ALDH1A1CYP1A2CYP2C19SLC6A4SLC6A2 | |
| SCHEMBL11027381 | 0.80 | HTR2A (0.38) | ALDH1A1CYP1A2CYP2C19SLC6A4SLC6A2 | |
| SCHEMBL4371661 | 0.79 | HTR2A (0.44) | SLC6A4HTR2A | |
| SCHEMBL14774694 | 0.79 | PTGER1 (0.48) | ALDH1A1SMN1; SMN2CYP1A2CYP2C19RAB9A | |
| SCHEMBL8290760 | 0.79 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2CYP1A2CYP2C19RAB9A | |
| SCHEMBL531667 | 0.79 | ALDH1A1 (0.43) | ALDH1A1SMN1; SMN2CYP1A2CYP2C19RAB9A | |
| SCHEMBL3307736 | 0.78 | IDO1 (0.40) | ALDH1A1SMN1; SMN2CYP1A2SLC6A4KDM4E | |
| SCHEMBL30149750 | 0.78 | IDO1 (0.40) | ALDH1A1SMN1; SMN2CYP1A2SLC6A4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 596 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119912847-A | Composite coating and application thereof | 万华化学集团股份有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-122071464-A | Heterocyclic compound, pharmaceutical composition thereof and application thereof | 上海璎黎药业有限公司 | 2026-05-22 | — | — | CN | disclosed |
| US-12577257-B2 | Heterocyclic compounds | HOFFMANN-LA ROCHE INC. (US) | 2026-03-17 | — | — | US | disclosed |
| US-20260007672-A1 | INHIBITORS OF MPTP | NRG THERAPEUTICS LTD (GB) | 2026-01-08 | — | — | US | disclosed |
| EP-4663640-A1 | XANTHINE COMPOUND AND USE THEREOF | Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) | 2025-12-17 | — | — | EP | disclosed |
| US-12491185-B2 | Inhibitors of mPTP | NRG THERAPEUTICS LTD (GB) | 2025-12-09 | — | — | US | disclosed |
| US-20250340557-A1 | PYRIMIDINE DERIVATIVE | ASKA PHARMACEUTICAL CO., LTD. (JP) | 2025-11-06 | — | — | US | disclosed |
| EP-4638436-A1 | PRMT5 INHIBITORS AND USES THEREOF | GILEAD SCIENCES, INC. (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20250312345-A1 | NON-COVALENT INHIBITORS OF THE MAIN PROTEASE OF SARS-COV-2 AND METHODS OF USE | UNIV YALE (US) | 2025-10-09 | — | — | US | disclosed |
| US-12435078-B2 | Pyridazinones and methods of use thereof | GFB (ABC), LLC (US) | 2025-10-07 | — | — | US | disclosed |
| US-6030979-A | INHIBITS THE STEROL 14-REDUCTASE WHICH CATALYZES THE BIOSYNTHESIS OF CHOLESTEROL FROM LANOSTEROL; ANTICHOLESTEROL AND-LIPEMIC AGENTS | HANWHA CORPORATION (CN) | 2000-02-29 | — | — | US | disclosed |
| US-6028197-A | ENZYME INHIBITORS INHIBITING THE STEROL 14-REDUCTASE WHICH IS INVOLVED IN THE DISTAL PATHWAY OF CHOLESTEROL BIOSYNTHESIS, AND THE USE AS ANTICHOLESTEROL AGENTS OR ANTILIPEMIC AGENTS | HANWHA CORPORATION (KR) | 2000-02-22 | — | — | US | disclosed |
| US-4846875-A | PLANT GROWTH REGULATORS | FMC CORPORATION (US) | 1989-07-11 | — | — | US | disclosed |
| US-4846882-A | HALOBENZYL DERIVATIVES | FMC CORPORATION (US) | 1989-07-11 | — | — | US | disclosed |
| CN-87100152-A | The compound of weeding | — | 1987-08-12 | — | — | CN | disclosed |
| WO-1987004049-A1 | N-SUBSTITUTED TETRAHYDROPHTHALIMIDE HERBICIDAL COMPOUNDS AND INTERMEDIATES THEREFOR | FMC CORPORATION (US) | 1987-07-16 | — | — | WO | disclosed |
| US-4567199-A | SOIL INSECTICIDES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1986-01-28 | — | — | US | disclosed |
| EP-0057795-B1 | HALOBENZYL ESTERS OF HALOALKENYLCYCLOPROPANE ACIDS, THEIR PREPARATION, COMPOSITIONS AND METHOD OF COMBATING INSECT PESTS THEREWITH | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-07-10 | — | — | EP | disclosed |
| US-4405357-A | Herbicidal 3-isoxazolidinones and hydroxamic acids | FMC CORPORATION (US) | 1983-09-20 | — | — | US | disclosed |
| EP-0057795-A1 | Halobenzyl esters of haloalkenylcyclopropane acids, their preparation, compositions and method of combating insect pests therewith | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1982-08-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250312345-A1 | NON-COVALENT INHIBITORS OF THE MAIN PROTEASE OF SARS-COV-2 AND METHODS OF USE | ACE2, ACE, TMPRSS2 | ALDH1A1 1642/4885SMN1; SMN2 2957/4885CYP1A2 219/4885 |
| US-12491185-B2 | Inhibitors of mPTP | PARK7, PINK1, SNCA | ALDH1A1 415/4885SMN1; SMN2 1036/4885CYP1A2 378/4885 |
| US-20250340557-A1 | PYRIMIDINE DERIVATIVE | PTGES, PTGS1, PTGIS | ALDH1A1 136/4885SMN1; SMN2 4007/4885CYP1A2 145/4885 |
| US-12435078-B2 | Pyridazinones and methods of use thereof | PDXK, ATP6V1B1, REN | ALDH1A1 649/4885SMN1; SMN2 2435/4885CYP1A2 70/4885 |
| US-20260007672-A1 | INHIBITORS OF MPTP | PARK7, SNCA, CYC1 | ALDH1A1 176/4885SMN1; SMN2 995/4885CYP1A2 1009/4885 |
| US-12577257-B2 | Heterocyclic compounds | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR1, CBR3 | ALDH1A1 1116/4885SMN1; SMN2 1111/4885CYP1A2 62/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.